Share Name Share Symbol Market Type Share ISIN Share Description
Abcam Plc LSE:ABC London Ordinary Share GB00B6774699 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +16.00p +1.15% 1,405.00p 1,396.00p 1,398.00p 1,412.00p 1,374.00p 1,374.00p 364,770 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 233.2 69.1 30.5 46.1 2,889

Abcam Share Discussion Threads

Showing 926 to 946 of 950 messages
Chat Pages: 38  37  36  35  34  33  32  31  30  29  28  27  Older
DateSubjectAuthorDiscuss
19/6/2019
12:13
Any thoughts on why we are dropping here?
lenzcrafter
09/6/2019
10:43
Just to give you guys something to chew one ... the bear case The Chart does stand at a point at which I feel a previous top is being tested IF it fails say due to macro market issues The bottom support suggests 1150p could be tested in a tiescale of approx 1 to 2 months based upon the last decent drop. dyor
buywell3
08/6/2019
20:56
But do they add an extra spread to the buy/sell price to make up for that ?
cokehookerscars
16/5/2019
12:04
This is a strong share. Why didn't I get in at £10 a share! Gggrrhh
lenzcrafter
29/4/2019
22:22
This board has become so quiet. Anyone has comments for the recent steady growth recovering above 1300p despite the drop today
claire1010
29/4/2019
20:24
Sorry EJGot a couple of premium stalkers from CNA thread giving all my posts the thumbs down, so just kept their message posting alert going all night.Sincere apologies, had my fun so no more "."
discodave4
11/4/2019
16:09
DiscoDave4 - you have spammed many different threads today with a punctuation mark. Is there some reason for such perverse activity?
erogenous jones
07/3/2019
16:12
Consistent dd growth in what? Diluted EPS and adjusted diluted EPS are calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all potentially dilutive ordinary shares. Such potentially dilutive ordinary shares comprise share options and awards granted to employees where the exercise price is less than the average market price of the Company's ordinary shares during the period and any unvested shares which have met, or are expected to meet, the performance conditions at the end of the reporting period. (Unaudited) (Unaudited) six months six months ended ended 31 Dec 2018 31 Dec 2017 ---------------------- ------------- ------------- Basic EPS 13.5p 15.8p Diluted EPS 13.4p 15.7p Adjusted basic EPS 16.4p 15.6p Adjusted diluted EPS 16.3p 15.5p ---------------------- ------------- ------------- Steady second half forecast doesnt justify retention of P/E ratio in excess of 30
phillis
07/3/2019
11:32
I hope this stay down for a little while longer so I can add more in April. Selfish I know.
ifthecapfits
07/3/2019
07:48
Agreed, great fundamentals, consistent double digit growth
sampsun
06/3/2019
20:49
Surely all positive here? Great solid fundamentals or am I missing something?
lenzcrafter
06/3/2019
15:09
Market disagrees with your thoughts Phillis. We shall see though if it does break £10
bulltradept
06/3/2019
08:28
So why don't you buy more? Because it is not a good buy at these levels
phillis
05/3/2019
15:26
Not in the least fussed about the drop yesterday, or the rise today, for that matter. Good, well managed and profitable company that has a track record of share price growth over many years. That was the case last week and remains the case this week. My average price is £6.50 and until the company ceases to be as profitable as in previous years I see no reason why I should not allow profits to run.
erogenous jones
05/3/2019
15:05
This needs to buy a good acquisition with growth potential again P/E too chunky
buywell2
05/3/2019
14:07
Sitting on a few % loss now after being on a decent (but not life changing) paper profit. Disappointing. Do we think EU companies are looking to support other EU companies instead of the UK with regard to ABCam ? I am surprised by the drop, this seems like a company with a pretty solid, almost cash cow element, to its business (leading supplier of protein research tools to life scientists) PLUS the excitement of further developments. Perhaps the market just expected a bit too much with 'traders' getting in on it heating the price a bit too much for now but that the growth will come in time.
cokehookerscars
05/3/2019
07:49
So if this breaks £10....
bulltradept
04/3/2019
22:05
on the other hand, if they fall very much, their huge library of validated antibodies might attract attention from other life sciences companies, maybe: would be a pity since uk needs its champions having already lost ARM and failed to make the most of the intellectual property of monoclonal antibodies first developed in Cambridge.
mw8156
04/3/2019
20:15
Huge p/e on slowing growth? Why hold? It is going to be a lot cheaper
phillis
04/3/2019
16:26
I/C Has hold on slower growth @ 10.50
bulltradept
04/3/2019
10:04
Flat second half Lots of "investment"
phillis
Chat Pages: 38  37  36  35  34  33  32  31  30  29  28  27  Older
Your Recent History
LSE
ABC
Abcam
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190719 20:48:58